In Vitro Considerations to Support Bioequivalence of Locally Acting Drugs in Dry Powder Inhalers for Lung Diseases

Dry powder inhalers (DPIs) are used to deliver locally acting drugs (e.g., bronchodilators and corticosteroids) for treatment of lung diseases such as asthma and chronic obstructive pulmonary disease (COPD). Demonstrating bioequivalence (BE) for DPI products is challenging, primarily due to an incom...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Lee, Sau Lawrence, Adams, Wallace P., Li, Bing V., Conner, Dale P., Chowdhury, Badrul A., Yu, Lawrence X.
פורמט: Artigo
שפה:Inglês
יצא לאור: Springer US 2009
נושאים:
Regulatory Note
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2758114/
https://ncbi.nlm.nih.gov/pubmed/19495991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-009-9121-4
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים